| 12 Week Efficacy of Tiotropium Versus Placebo in Patients With Mild COPD According to Swedish Guidelines (SPIRIMILD) (NCT00144196) | Boehringer Ingelheim | 2004-03-11 |
| Berodual® Respimat® Solution for Inhalation in Patients With Chronic Obstructive Airways Disease (NCT02231372) | Boehringer Ingelheim | 2004-03-01 |
| Tiotropium 18ug Inhalation Capsule Using a Handihaler® Among Korean COPD Patients (NCT00620516) | Boehringer Ingelheim | 2004-03-01 |
| Effect of Tiotropium Inhalation Capsules on Exercise Tolerance, Daily Activity and Dyspnoea in Patients With Chronic Obstructive Pulmonary Disease (COPD) Participating in 3 Weeks of Pulmonary Rehabilitation (NCT02172508) | Boehringer Ingelheim | 2004-01-01 |
| Berodual® Respimat® Solution for Inhalation in Patients With Chronic Obstructive Airways Disease (NCT02231359) | Boehringer Ingelheim | 2004-01-01 |
| Effective High Aerobic Intensity Endurance Training Regimes in Chronic Obstructive Pulmonary Disease (COPD) Patients (NCT00658853) | Norwegian University of Science and Technology | 2004-01-01 |
| Effectiveness of Home Automated Telemanagement in Chronic Obstructive Pulmonary Disorder (NCT00752531) | Johns Hopkins University | 2003-12-01 |
| A Six-week Study Comparing the Efficacy and Safety of Tiotropium Plus Formoterol to Salmeterol Plus Fluticasone in Chronic Obstructive Pulmonary Disease (COPD) (NCT00239421) | Boehringer Ingelheim | 2003-11-01 |
| Treatment Of Partial Reversible Chronic Obstructive Pulmonary Disease (NCT00549146) | GlaxoSmithKline | 2003-11-01 |
| Free Combinations of Tiotropium Inhalation Powder Capsule + Salmeterol Metered Dose Inhaler, Tiotropium Inhalation Powder Capsule and Salmeterol Metered Dose Inhaler in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT02242253) | Boehringer Ingelheim | 2003-09-01 |
| Pilot Study Comparing Tiotropium (Spiriva) to Salmeterol (Serevent) Plus Fluticasone (Flixotide) in Chronic Obstructive Pulmonary Disease (COPD) (NCT00239499) | Boehringer Ingelheim | 2003-09-01 |
| SERETIDE 50/500mcg Versus Tiotropium Bromide On Exacerbation Rates In Severe Chronic Obstructive Pulmonary Disease (NCT00361959) | GlaxoSmithKline | 2003-06-01 |
| A Comparison of 18g of Tiotropium Inhalation Capsules Once Daily and Atrovent Metered Dose Inhaler (2 Puffs of 20g, 4 Times Daily) in a Double-Blind, Double-Dummy, Efficacy and Safety Study in Adults With Chronic Obstructive Pulmonary Disease (COPD) (NCT00239434) | Boehringer Ingelheim | 2003-06-01 |
| AMBULATORY OXIMETRY MONITORING (AOM): a New Approach to Quantify Oxygen Desaturation in Ambulatory COPD Patients (NCT01873092) | VA New York Harbor Healthcare System | 2003-05-01 |
| Evaluation of the Role of Nocturnal Non-Invasive Ventilation in Pulmonary Rehabilitation (NCT00710463) | Deutsche Lungenstiftung e.V. | 2003-05-01 |
| Tiotropium / Respimat One-Year Study (NCT00168831) | Boehringer Ingelheim | 2003-02-01 |
| Negative Pressure Ventilator in Long-term Pulmonary Rehabilitation for Chronic Obstructive Pulmonary Disease (NCT03540862) | Chang Gung Memorial Hospital | 2003-01-01 |
| Tiotropium / Respimat One-Year Study (NCT00168844) | Boehringer Ingelheim | 2003-01-01 |
| Evaluation of Spirometry Expert Support in General Practice (NCT00131157) | Radboud University Medical Center | 2003-01-01 |
| Yoga for Treating Shortness of Breath in Chronic Obstructive Pulmonary Disease (COPD) (NCT00051792) | National Center for Complementary and Integrative Health (NCCIH) | 2003-01-01 |
| A Study of MK0359 in Patients With Chronic Obstructive Pulmonary Disease (COPD)(0359-016) (NCT00482235) | Merck Sharp & Dohme LLC | 2002-12-01 |
| Evaluation of the Long- Term Effects of Spiriva on Lung Function in COPD Patients (NCT00144339) | Boehringer Ingelheim | 2002-12-01 |
| Spiriva (Tiotropium Bromide) Assessment of FEV1 - (SAFE-Portugal). (NCT00239408) | Boehringer Ingelheim | 2002-12-01 |
| 12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPD (NCT00240435) | Boehringer Ingelheim | 2002-11-01 |
| Airway Inflammation In Patients With Chronic Obstructive Pulmonary Disease (NCT00268177) | GlaxoSmithKline | 2002-10-01 |
| SPIRIVA in Ususal Care (NCT00274079) | Boehringer Ingelheim | 2002-10-01 |
| Ipratropium Bromide/Salbutamol Delivered by the Respimat® Inhaler Compared to Ipratropium Bromide Respimat®, COMBIVENT® Inhalation Aerosol and Placebo in Adults With Chronic Obstructive Pulmonary Disease (NCT02177253) | Boehringer Ingelheim | 2002-10-01 |
| Acute Bronchodilator Response of a Single Dose of Atrovent or Berotec on Top of Pharmacodynamic Steady State of Spiriva (NCT00274066) | Boehringer Ingelheim | 2002-10-01 |
| Berodual® Respimat® Versus Berodual® Metered Aerosol (MA) Inhaler in Patients With Asthma, Chronic Obstructive Pulmonary Disease, or Mixed Condition (NCT02173795) | Boehringer Ingelheim | 2002-10-01 |
| A Prescription-Event Monitoring (PEM) Study of Tiotropium (NCT02196194) | Boehringer Ingelheim | 2002-09-01 |
| Efficacy and Safety of Tiotropium Inhalation Capsules and Atrovent MDI in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT00274092) | Boehringer Ingelheim | 2002-09-01 |
| Effect of Tiotropium Inhalation Capsules (Spiriva) on Exercise Tolerance in COPD Patients (NCT00157235) | Boehringer Ingelheim | 2002-09-01 |
| Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in Chronic Obstructive Pulmonary Disease (COPD) (NCT00281567) | Boehringer Ingelheim | 2002-08-01 |
| A Cognitive-Behavioral Intervention for Depression and Anxiety in COPD (NCT00105911) | US Department of Veterans Affairs | 2002-07-01 |
| Comparison of Tiotropium and Ipratropium in a Double-Blind, Double-dummy, Efficacy and Safety Study in Adults With COPD (NCT00274040) | Boehringer Ingelheim | 2002-07-01 |
| Spiriva® in Patients With Chronic Obstructive Pulmonary Disease (COPD) in Daily Practice (NCT02172495) | Boehringer Ingelheim | 2002-06-01 |
| Evaluation of the Lung Deposition Rate and Distribution Pattern of Tiotropium Via HandiHalerTM in Healthy Subjects and Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT02172456) | Boehringer Ingelheim | 2002-05-01 |
| Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol on Muscular Efficiency and Resting Energy Expenditure (REE) in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD) (NCT02172794) | Boehringer Ingelheim | 2002-05-01 |
| A Multiple Dose Comparison of Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol. (NCT00274560) | Boehringer Ingelheim | 2002-05-01 |
| Effects of a 9-months Treatment of SPIRIVA on Health Related Quality of Life in Patients With COPD (NCT00274053) | Boehringer Ingelheim | 2002-04-01 |
| Multidisciplinary Inpatient Palliative Care Intervention (NCT00325611) | Kaiser Permanente | 2002-04-01 |
| Effects of Once Daily Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD) of Different Severity (NCT00274573) | Boehringer Ingelheim | 2002-03-01 |
| Treatment of Depressed Chronic Obstructive Pulmonary Disease Patients (NCT00151372) | Weill Medical College of Cornell University | 2002-03-01 |
| Efficacy and Safety of Free Combination of Tiotropium + Formoterol Compared to Formoterol and Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT02238119) | Boehringer Ingelheim | 2002-02-01 |
| Spiriva® Assessment of FEV1 (SAFE) (NCT00277264) | Boehringer Ingelheim | 2002-01-01 |
| (Cost-)Effectiveness Interdisciplinary Community-based COPD Management Program (INTERCOM) (NCT00840892) | Maastricht University Medical Center | 2002-01-01 |
| Comparison of Two Programs to Encourage Physical Activity in Individuals With Chronic Obstructive Pulmonary Disease (NCT00328484) | National Heart, Lung, and Blood Institute (NHLBI) | 2002-01-01 |
| A Blinded Study Comparing the Safety and Efficacy of a Fully Human Anti-IL8 Monoclonal Antibody (ABX-IL8) to Placebo in Patients With Chronic Bronchitis and COPD (NCT00035828) | Abgenix | 2001-12-01 |
| Interest of a 30 Minutes' Intermittent Work Exercise Test in Patients With Chronic Obstructive Pulmonary Disease: Cardiac and Pulmonary Functions (NCT00295113) | University Hospital, Strasbourg, France | 2001-11-01 |
| Tiotropium (18 Mcg) Once Daily Via the HandiHaler® in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT00274547) | Boehringer Ingelheim | 2001-09-01 |
| Comparison of Tiotropium Inhalation Capsules and Atrovent Metered Dose Inhaler (MDI) in a Efficacy and Safety Study in Adults With Chronic Obstructive Pulmonary Disease (NCT02172443) | Boehringer Ingelheim | 2001-06-01 |
| Tiotropium (Spiriva) Rehabilitation Study (NCT00274521) | Boehringer Ingelheim | 2001-05-01 |
| Prophylactic Antibiotic Treatment of Patients With Chronic Obstructive Lung Disease (COLD) (NCT00132860) | Odense University Hospital | 2001-05-01 |
| Effect of Treatment With BIIL 284 BS on Exercise Endurance in Patients With Chronic Obstructive Pulmonary Disease (NCT02249247) | Boehringer Ingelheim | 2001-04-01 |
| Combivent® HFA-propelled Compared to CFC-propelled Metered Dose Inhaler in Patients With COPD (Chronic Obstructive Pulmonary Disease) (NCT02182869) | Boehringer Ingelheim | 2001-04-01 |
| Lung Function Changes Following the Addition of Formoterol to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT02242240) | Boehringer Ingelheim | 2001-03-01 |
| Postmarketing Surveillance Study of Atrovent® Inhalation Solution in Chronic Obstructive Pulmonary Disease (NCT02238197) | Boehringer Ingelheim | 2001-02-01 |
| Post-marketing Surveillance of Atrovent® Inhalets in Chronic Obstructive Pulmonary Disease (NCT02233894) | Boehringer Ingelheim | 2001-02-01 |
| Post-marketing Surveillance of Atrovent® in Chronic Obstructive Pulmonary Disease (NCT02233881) | Boehringer Ingelheim | 2001-01-01 |
| Mechanisms of Dyspnea Relief During Exercise in COPD Patients Following Treatment With Tiotropium (Spiriva) (NCT00274027) | Boehringer Ingelheim | 2001-01-01 |
| Efficacy and Safety of Ba679BR Powder Inhalation in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT02172807) | Boehringer Ingelheim | 2000-12-01 |
| A Comparison of the Effects of Tiotropium Inhalation qd and Salmeterol Inhalation Bid on Arterial Blood Gases. (NCT00274534) | Boehringer Ingelheim | 2000-12-01 |
| Effect of Tiotropium on Airway Diameter in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT02172391) | Boehringer Ingelheim | 2000-11-01 |
| Effect of Tiotropium (Spiriva) on Exercise Tolerance in COPD Patients (NCT00274508) | Boehringer Ingelheim | 2000-10-10 |
| Comparison of Safety and Efficacy of COMBIVENT HFA to COMBIVENT (CFC) in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT02194205) | Boehringer Ingelheim | 2000-10-01 |
| Trial to Determine the Comparability of Ipratropium Bromide Hydrofluoroalkane (HFA)-134a Inhalation Aerosol to ATROVENT® Chlorofluorocarbon (CFC) Inhalation Aerosol, in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT02236169) | Boehringer Ingelheim | 2000-10-01 |
| HandiHaler® vs. Metered Dose Inhaler (MDI) in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT02172404) | Boehringer Ingelheim | 2000-10-01 |
| Measure of the Long Term Influence of SPIRIVA® in Acute Respiratory Disorders (NCT00274014) | Boehringer Ingelheim | 2000-10-01 |
| A Confirmation Study of Combivent HFA Inhalation Aerosol in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT02182674) | Boehringer Ingelheim | 2000-10-01 |
| Study of the Comparability of Ipratropium Bromide Hydrofluoroalkane (HFA)-134a Inhalation Aerosol to the Market Standard, Atrovent® Chlorofluorocarbon (CFC) Inhalation Aerosol, in Patients With Chronic Obstructive Pulmonary Disease (NCT02260011) | Boehringer Ingelheim | 2000-10-01 |
| Survival Of Subjects With Chronic Obstructive Pulmonary Disease (COPD) (NCT00268216) | GlaxoSmithKline | 2000-09-01 |
| Comparison of Tiotropium Inhalation Capsules and Oxitropium Metered Dose Inhalator (MDI) in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT02172430) | Boehringer Ingelheim | 2000-09-01 |
| Effect of Ventilation-Feedback Training on Exercise Performance in COPD (NCT00037973) | US Department of Veterans Affairs | 2000-08-01 |
| 12-week Treatment With Inhaled Tiotropium (18 mcg Once Daily) on Lung Function and Static Lung Volumes in Stable, Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Patients. Correlation to Dyspnoea Scales (NCT02172378) | Boehringer Ingelheim | 2000-05-01 |
| Postmarketing Surveillance Study of Atrovent® Inhalets in Chronic Obstructive Pulmonary Disease (NCT02238171) | Boehringer Ingelheim | 2000-04-01 |
| Postmarketing Surveillance Study of Berotec® N 100 µg Metered-dose Inhaler in Chronic Obstructive Respiratory Tract Disease (NCT02244216) | Boehringer Ingelheim | 2000-04-01 |
| Evaluating the Effects of Surgical and Non-Surgical Treatment Options in People With Emphysema (NCT00675454) | Washington University School of Medicine | 2000-01-01 |
| Post-marketing Surveillance of Ventilat® Metered Dose Inhaler in Chronic Obstructive Bronchitis (NCT02233920) | Boehringer Ingelheim | 2000-01-01 |
| Effect of BIIL 284 BS on Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT02249338) | Boehringer Ingelheim | 1999-10-01 |
| Postmarketing Surveillance Study of Atrovent® in Chronic Obstructive Airways Disease (NCT02236715) | Boehringer Ingelheim | 1999-09-01 |
| Postmarketing Surveillance of Atrovent® in Chronic Obstructive Pulmonary Disease (NCT02238158) | Boehringer Ingelheim | 1999-09-01 |
| Inhaled Bronchodilator Association and Quality of Life in Patients With Chronic Obstructive Pulmonary Disease (NCT02176564) | Boehringer Ingelheim | 1999-06-01 |
| Effect of Tiotropium on Exercise Tolerance in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT02172300) | Boehringer Ingelheim | 1999-06-01 |
| Efficacy and Safety of Tiotropium Compared to Salmeterol and Placebo in Patients With Chronic Obstructive Bronchitis (COPD) (NCT02173691) | Boehringer Ingelheim | 1999-02-01 |
| Multiple Dose Comparison of Tiotropium Inhalation Capsules, Salmeterol Inhalation Aerosol and Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT02172287) | Boehringer Ingelheim | 1999-02-01 |
| Postmarketing Surveillance Study of Atrovent® Inhaletten® in Chronic Obstructive Airways Disease (NCT02238145) | Boehringer Ingelheim | 1999-01-01 |
| Postmarketing Surveillance Study of Berodual® Metered-dose Inhaler in Chronic Obstructive Airways Disease (NCT02231424) | Boehringer Ingelheim | 1999-01-01 |
| Post-marketing Surveillance of Berodual® Metered-dose Inhaler in the Treatment of Chronic Obstructive Respiratory Tract Disease (NCT02231437) | Boehringer Ingelheim | 1999-01-01 |
| COPD on Primary Care Treatment (COOPT) (NCT00184977) | Radboud University Medical Center | 1998-12-01 |
| Postmarketing Surveillance Study of Atrovent® Inhalets in Chronic Obstructive Airways Disease (NCT02238132) | Boehringer Ingelheim | 1998-12-01 |
| LIFE-Lung Bronchoscopy in Patients at Risk for Developing Lung Cancer (NCT00260598) | University of Pittsburgh | 1998-08-01 |
| Safety and Efficacy of Two Different Doses of Ipratropium Bromide Versus ATROVENT® Inhalation Aerosol in Adults With Chronic Obstructive Pulmonary Disease (NCT02177344) | Boehringer Ingelheim | 1998-08-01 |
| Dose Ranging Study of Ba 679 BR Inhalation Powder in Chronic Obstructive Pulmonary Disease (COPD) Patients (NCT02172352) | Boehringer Ingelheim | 1998-07-01 |
| Study to Assess the Safety of Ipratropium Bromide, in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT02236182) | Boehringer Ingelheim | 1998-07-01 |
| Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Respimat Device in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT02175342) | Boehringer Ingelheim | 1998-03-01 |
| Pharmacokinetic Study in Elderly Patients With Chronic Obstructive Bronchitis (COPD) (NCT02172326) | Boehringer Ingelheim | 1998-02-01 |
| Ipratropium or Salbutamol Sulphate Alone or Combination Therapy Salbutamol and Ipratropium in Patients With COPD (NCT02182856) | Boehringer Ingelheim | 1998-02-01 |
| Comparison of Safety and Efficacy of Berodual® Administered Via the Respimat® Device With That Administered Via the Metered Dose Inhaler (MDI) in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT02173782) | Boehringer Ingelheim | 1998-02-01 |
| Prognostic Value of Prothrombin Fragments 1+2 for Pulmonary Embolism Incidence (NCT01078792) | Hillel Yaffe Medical Center | |